Related Experiment Videos
[Facial mucormycosis: observations from three cases]
T Sellami-Boudawara1, N Gouiaa, I Charfeddine
1Laboratoire d'Anatomie et de Cytologie Pathologique, EPS, Habib Bourguiba de Sfax.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale
|January 23, 2003
Summary
Mucormycosis is a rare fungal infection affecting immunocompromised individuals, especially diabetics. Diagnosis relies on mycological and pathological exams, with treatment involving antifungals and surgery.
Area of Science:
- Mycology
- Infectious Diseases
- Pathology
Background:
- Mucormycosis is a rare, opportunistic invasive fungal infection caused by Mucorales fungi.
- Characterized by vascular invasion and tissue necrosis, it primarily affects individuals with compromised immunity, particularly diabetics.
- The cerebro-rhino-orbital region is the most commonly affected site.
Observation:
- Three cases of mucormycosis are reported: one male (42 years) and two females (59 and 60 years).
- Diabetes mellitus was a comorbidity in two of the three observed cases.
- Diagnosis in all reported cases was confirmed through anatomo-pathological examination.
Findings:
- The study aimed to investigate the epidemiological and clinico-pathologic features of mucormycosis.
- Clinical signs are influenced by the fungi's intra-tissular and intra-vascular progression.
- Confirmed diagnosis was achieved via mycological and anatomo-pathological assessments.
Implications:
- Early diagnosis and prompt treatment, including antifungal therapy and surgical debridement, are crucial for managing mucormycosis.
- Understanding the clinico-pathologic aspects is vital for improving patient prognosis.
- Further research into risk factors and treatment strategies for this severe infection is warranted.